MariMed officer exercises RSUs, settles taxes in shares

MariMed Inc. Chief Commercial Officer Ryan Crandall exercised vested equity awards and settled taxes in shares.

Rhea-AI Filing Summary

MariMed Inc. Chief Commercial Officer Ryan Crandall exercised vested equity awards and settled taxes in shares. On March 28, 2026, he converted 6,047 Restricted Stock Units (RSUs) into the same number of common shares at an exercise price of $0.00 per share.

Of these shares, 2,096 common shares were withheld by MariMed at a value of $0.0758 per share to satisfy tax withholding obligations, with the remainder added to his holdings. Following these transactions, Crandall directly held 879,634 shares of common stock. The RSUs originated from a March 28, 2024 grant, with an additional 6,046 RSUs scheduled to vest on September 28, 2026 and 6,047 RSUs on March 28, 2027.

Insider Trade Summary

6,047 shares exercised/converted

Exercise 3 txns

Insider Crandall Ryan

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	6,047	$0.00	$0.00
Exercise	Common stock	6,047	$0.00	$0.00
Exercise Price or Tax Liability	Common stock	2,096	$0.0758	$158.88

Holdings After Transaction: Restricted Stock Units (RSU) — 12,093 contracts (Direct); Common stock — 879,634 shares (Direct)

Footnotes (3)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. These RSUs were granted on March 28, 2024; of the remaining RSUs under this grant, 6,046 will vest on September 28, 2026 and 6,047 will vest on March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 6,047 units Exercise price: $0.00 per share Shares withheld for taxes: 2,096 shares +4 more

7 metrics

RSUs exercised 6,047 units Restricted Stock Units converted to common shares on March 28, 2026

Exercise price $0.00 per share Conversion of RSUs into MariMed common stock

Shares withheld for taxes 2,096 shares Common shares withheld to satisfy tax obligations at $0.0758 per share

Tax withholding share value $0.0758 per share Value used for shares withheld to pay tax liabilities

Post-transaction holdings 879,634 shares MariMed common stock held directly by Ryan Crandall after transactions

Future RSUs vesting 2026 6,046 units RSUs from March 28, 2024 grant vesting on September 28, 2026

Future RSUs vesting 2027 6,047 units RSUs from March 28, 2024 grant vesting on March 28, 2027

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, vesting

3 terms

Restricted Stock Units (RSU) financial

"RSUs convert to shares of common stock on a one-for-one basis."

tax withholding obligations financial

"Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations"

vesting financial

"These RSUs were granted on March 28, 2024; of the remaining RSUs under this grant, 6,046 will vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 07:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crandall Ryan

(Last) (First) (Middle)

10 OCEANA WAY, 2ND FLOOR

(Street)

NORWOOD MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	03/28/2026		M		6,047	A	$0(1)	881,730	D
Common stock	03/28/2026		F		2,096(2)	D	$0.0758	879,634	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	03/28/2026		M			6,047	(3)	(3)	Common Stock, par value $.001 per share	6,047	$0	12,093	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These RSUs were granted on March 28, 2024; of the remaining RSUs under this grant, 6,046 will vest on September 28, 2026 and 6,047 will vest on March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Ryan Crandall	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)